Sector Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Stocks
OJU1
US68403P2039
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
07:01:01 09/09/2026 BST
|
Pre-market 06:08:47 | |||
| 4.220 EUR | -0.59% |
|
4.120 | -2.37% |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
| 08-10 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.24% | -7.78% | -5.98% | +8.62% | +0.04% | -5.35% | +11.20% | -30.27% | +194.79% | 46.38B | |
| +0.17% | -0.74% | +1.23% | +38.87% | +160.74% | +407.28% | +546.58% | +579.80% | - | 44.51B | |
| -0.86% | -2.60% | +7.66% | +37.98% | +14.01% | +35.51% | +20.35% | -1.65% | +233.44% | 42.3B | |
| -0.14% | -2.98% | +0.78% | +30.89% | +15.53% | -0.04% | +82.21% | +4.05% | +1,059.18% | 39.91B | |
| 0.00% | -1.72% | -8.13% | +7.71% | +6.22% | +13.42% | +42.33% | -17.21% | +139.05% | 32.79B | |
| -3.44% | -2.43% | +2.11% | +22.31% | - | - | - | - | - | 17.13B | |
| -0.78% | -1.13% | -0.74% | +25.60% | +4.39% | +20.74% | +116.26% | +203.48% | +1,884.09% | 16.36B | |
| -0.37% | -2.53% | +1.63% | +9.17% | +13.69% | +10.91% | +30.93% | -42.85% | +88.27% | 14.31B | |
| -0.86% | -4.60% | +4.06% | +46.62% | +39.54% | +76.86% | +39.36% | -37.17% | +253.42% | 13.29B | |
| +0.74% | -0.21% | -3.04% | +5.07% | -12.46% | -5.58% | -36.23% | -38.40% | +112.28% | 12.31B | |
| -4.68% | -1.07% | +17.73% | +25.52% | +3.78% | -24.36% | - | - | - | 11.06B | |
| -0.08% | -0.07% | -0.06% | +32.79% | +22.85% | +33.30% | +0.60% | -43.13% | +172.33% | 11.33B | |
| -2.50% | -0.86% | -7.93% | +87.79% | +46.64% | +31.14% | +54.18% | -51.14% | - | 10.49B | |
| +0.20% | +4.71% | -11.31% | +17.95% | -15.95% | +32.46% | +495.29% | +182.29% | +2,449.12% | 10.25B | |
| -2.04% | -3.41% | -4.29% | +37.94% | +17.15% | +762.60% | +1,556.12% | +14.07% | - | 9.64B | |
| -0.89% | -2.70% | +7.36% | +50.08% | +48.35% | +165.48% | +509.45% | +79.88% | - | 9.6B | |
| -3.92% | -10.85% | +33.94% | +178.01% | +160.55% | +86.30% | +68.89% | -4.96% | +1,306.96% | 9.39B | |
| -0.58% | -0.68% | -0.53% | +37.05% | +66.12% | +148.61% | +661.63% | +216.65% | +1,070.08% | 9.39B | |
| -1.22% | -8.66% | -0.95% | -24.89% | -29.19% | -13.01% | +35.94% | +54.50% | +93.11% | 9.31B | |
| Average | -1.29% | -2.48% | +1.77% | +35.53% | +31.22% | +98.68% | +249.12% | +62.82% | +696.62% | 19.46B | |
| Weighted average by Cap. | -1.14% | -2.74% | +0.71% | +30.37% | +34.95% | +93.76% | +191.88% | +87.61% | +571.71% |
- Stock Market
- Stocks
- ORMP Stock
- OJU1 Stock
- Sector Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
